Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Andrea Murphy

Nurse Practitioner South Windsor, CT Nurse Practitioner

NPI 1467709097 CMS profile 10747393

1741 Ellington Rd, South Windsor, CT 06074

Open in the dashboard

General payments

$9,674

195 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Andrea Murphy of South Windsor, CT is reported in the CMS Open Payments database as having received $9,674 across 195 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,195 78
2024 General $2,416 46
2023 General $2,643 20
2022 General $695 23
2021 General $725 28

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrea Murphy
  • Nurse Practitioner median
  • Middle half of Nurse Practitioner
  • National median

In program year 2025, general payments to Andrea Murphy were reported at $3,195. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.

Show as a table
Year Andrea Murphy Nurse Practitioner median Middle half National median
2019 $0 $50 $22–$97 $163
2020 $0 $40 $16–$108 $114
2021 $725 $135 $40–$426 $132
2022 $695 $152 $48–$470 $149
2023 $2,643 $166 $54–$529 $160
2024 $2,416 $173 $55–$556 $164
2025 $3,195 $174 $55–$557 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Lundbeck LLC $2,684 10 payments
  2. AbbVie, Inc. $2,373 92 payments
  3. Astellas Pharma US Inc $1,995 1 payment
  4. Pfizer Inc. $773 36 payments
  5. Teva Pharmaceuticals USA, Inc. $309 8 payments
  6. Lilly USA, LLC $306 11 payments
  7. Amgen Inc. $218 2 payments
  8. Biohaven Pharmaceutical Holding Company Ltd. $206 7 payments
  9. Tonix Pharmaceuticals, Inc. $180 6 payments
  10. Axsome Therapeutics, Inc. $168 7 payments
  11. Other $461 15 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $5,269 192 payments
  2. Consulting Fee $4,405 3 payments
Products named General payments · program years 2021–2025
  1. VYEPTI $2,684 10 payments
  2. UBRELVY $1,809 75 payments
  3. QULIPTA $968 42 payments
  4. NURTEC ODT Pain $725 34 payments
  5. ZAVZPRET $689 30 payments
  6. NURTEC ODT Primary Care $306 10 payments
  7. AJOVY $292 7 payments
  8. EMGALITY $284 10 payments
  9. AIMOVIG $218 2 payments
  10. Symbravo $168 7 payments
  11. Other $905 33 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

195 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner in Connecticut

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record